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ABSTRACT
Medication errors involving insulin in hospital are common, 
and may be particularly problematic at the point of transfer 
of care. Our aim was to improve the safety of insulin 
prescribing on discharge from hospital using a continuous 
improvement methodology involving cycles of iterative 
change. A multidisciplinary project team formulated 
locally tailored insulin discharge prescribing guidance. 
After baseline data collection, three ‘plan-do-study-act’ 
cycles were undertaken over a 3-week period (September/
October 2018) to introduce the guidelines and improve the 
quality of discharge prescriptions from one diabetes ward 
at the hospital. Discharge prescriptions involving insulin 
from the ward during Monday to Friday of each week were 
examined, and their adherence to the guidance measured. 
After the introduction of the guidelines in the form of a 
poster, and later a checklist, the adherence to guidelines 
rose from an average of 50% to 99%. Qualitative data 
suggested that although it took pharmacists slightly longer 
to clinically verify discharge prescriptions, the interventions 
resulted in a clear and helpful reminder to help improve 
discharge quality for the benefit of patient safety. This 
project highlights that small iterative changes made by a 
multidisciplinary project team can result in improvement 
of insulin discharge prescription quality. The sustainability 
and scale of the intervention may be improved by its 
integration into the electronic prescribing system so that 
all users may access and refer to the guidance when 
prescribing insulin for patients at the point of discharge.
Problem
Insulin is a high-risk, critical medicine widely 
used in the treatment of diabetes mellitus, 
where inappropriate use can lead to poor 
glycaemic control, patient harm or even 
death.1 2 Errors involving insulin remain 
common, despite various local and national 
initiatives to decrease their number, and are 
particularly prevalent in hospital at the point-
of-care transfer.3–7
Sheffield Teaching Hospitals NHS Foun-
dation Trust (STHFT) is one of the largest 
and busiest National Health Service (NHS) 
hospital trusts in England, operating across 
five hospitals and 40 community sites. Over 
2.3 million patients a year are seen at STHFT, 
15% of whom have a diagnosis of diabetes. 
Like many other large teaching hospitals, 
staffing pressures and busy working envi-
ronments may jeopardise safe and accu-
rate insulin prescribing, particularly due to 
the complex nature of the medication and 
prescribing processes. The prescribing of 
insulin at the trust has been subject to the 
phased introduction of inpatient electronic 
prescribing and medicines administration 
(EPMA) over the past year, which has further 
complicated the prescribing process locally.
Although a variety of insulin safety measures 
have been introduced at STHFT, such as 
e-learning modules, specialist diabetes link 
nurses, dedicated insulin charts, specific 
foundation doctor training and EPMA, there 
have been consistently high levels of insulin 
errors being reported locally, and insulin is 
still one of the top medications implicated in 
medication errors at the hospital.
Clinical audits and previous research into 
insulin errors at the hospital showed that 
between 46% and 86% of patients prescribed 
insulin experience at least one insulin error 
during their stay; and despite the use of elec-
tronic discharge summaries for a number of 
years, insulin errors persist and are consid-
ered preventable by staff.6–8
In order to further explore insulin errors 
during EPMA implementation at STHFT, 
the diabetes pharmacy team conducted a 
6-month, retrospective thematic analysis 
of local medication safety incident reports 
involving insulin errors (online supple-
mentary figure S1, table S1). In light of 
the recently reported errors, it was felt that 
systems and processes could be further opti-
mised for the benefit of patient safety, partic-
ularly in the period of initial implementation 
and development of EPMA. The results were 
discussed with the diabetes inpatient service 
improvement team at the hospital, and due 
to the prevalence and nature of reported 
errors at discharge, it was agreed that the 
quality of insulin discharge prescriptions 
should be the focus of quality improvement 
(QI) efforts.
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A multidisciplinary project team, led by a pharmacist 
academic practitioner, was established from members 
of the diabetes inpatient service improvement team and 
included consultant diabetologists, diabetes inpatient 
specialist nurses, and diabetes pharmacists and phar-
macy technicians. After examination of both previous 
and existing systems and measures to promote the safe 
prescribing of insulin at the point of discharge (both 
at STHFT and nationally), the project team decided to 
develop a set of consensus-derived discharge prescribing 
guidelines concerning insulin (online supplementary 
table S2). These were created in line with national guid-
ance such as the Joint British Diabetes Societies’ Guide-
lines on discharge planning9 but tailored to the local 
context.
background
Medication errors have previously been described as 
‘common’ at the point of discharge,5 10 and can include 
the unintended omission of medication, continuation/
re-prescribing of an intentionally stopped medication, 
or an error in medication dose, frequency or formula-
tion.11 If discharge prescription errors are not rectified, 
they may persist in the community, thus posing an even 
greater threat to patient safety.12
The implementation of electronic communication 
systems and medicines reconciliation processes have 
been recommended to reduce medication errors at the 
point of discharge.13–15 The impact of medicines recon-
ciliation on insulin prescribing quality was previously 
studied at the trust with positive results,7 but the impact 
of this process at the point of discharge has not yet been 
examined locally. Although electronic discharge summa-
ries have been in use for a number of years at STHFT, 
insulin discharge prescriptions were often found to 
contain insufficient information for general practitioners 
and community care providers.6
The impact of insulin prescribing errors at the point 
of discharge for people using insulin may be particularly 
severe due to the increased risk associated with its use. 
Previously, high volumes of insulin-related patient safety 
incident reports prompted the National Patient Safety 
Agency (now part of NHS Improvement) to issue a rapid 
response alert to NHS providers in 2010, instructing them 
to make changes to the way insulin was prescribed.16 
These included writing ‘units’ instead of ‘u’ or ‘iu’, the 
provision of training for all healthcare staff involved with 
insulin and the introduction of an ‘Insulin Passport’, 
where contemporaneous insulin details can be kept with 
the patient throughout their care journey.17
Despite this, the National Diabetes Inpatient Audit 
has shown consistently high levels of insulin errors since 
2011; in 2017, 4 out of 10 inpatients with insulin-treated 
diabetes experienced an insulin error in England and 
Wales.4 Despite the promotion of EPMA as a strategy to 
reduce insulin errors, insulin prescribing errors are only 
slightly less likely to occur at trusts using EPMA (17.2% 
cf 18.9%), and often persist despite its introduction.4 8 
The success of the Insulin Passport has also been limited, 
prompting the discontinuation of their routine use at 
STHFT as well as elsewhere in the UK.18
It is evident that erroneous insulin prescribing is still 
prevalent and problematic, particularly at the point 
of discharge. A recent systematic review on insulin 
prescribing interventions concluded that implementing 
strategies that are sensitive to local context and designed 
to increase adherence to insulin prescribing guidelines 
are associated with a reduction in prescribing errors.19
Approaches to reducing risk with insulin prescribing 
at discharge are variable and subject to differences in 
guidance interpretation and local influences.20 Previous 
QI interventions in the UK have involved root cause anal-
ysis, the introduction of a regional inpatient drug chart, 
insulin safety posters, prompts, educational tools and 
comprehensive discharge checklists.21–25 A recent failure 
modes, effects and criticality analysis identified a number 
of factors involved in the failures of the discharge process 
for patients using insulin, including variability in delivery 
of diabetes education and training, care coordination and 
medication prescribing patterns.26 The resulting recom-
mendations to improve prescribing and reduce medica-
tion errors included implementing institution-specific, 
validated, consensus-derived discharge guidelines which 
could be embedded within an electronic health record 
decision support tool.
In light of the recent problems with insulin prescribing 
at discharge at STHFT, as well the wider issues of 
insulin prescribing safety both in the UK and globally, 
this project focused on improving the quality of elec-
tronic insulin prescribing at the point of discharge from 
hospital through the use of continuous improvement 
methodology.
Patient and public involvement
Although not directly involved in the design of the inter-
ventions included in this project, the STHFT diabetes 
patient public involvement group was consulted and 
gave their support to the idea and need for the insulin 
prescribing safety project, which was informed by their 
concerns around communication issues and not feeling in 
control of their insulin in hospital. The group expressed 
interest in disseminating findings and involvement in the 
ongoing wider research in this area at the Trust.
measuremenT
In order to investigate the extent of the current problem, 
baseline data were retrospectively collected from the 
10 most recent electronic patient discharge prescrip-
tions involving insulin from one diabetes ward during 1 
week (Monday–Friday) by a single pharmacist. The ward 
was chosen in light of its comparatively high volume of 
reported insulin errors and greater proportion of patients 
being prescribed insulin compared with other wards. 
A proforma was used to record completed discharge 
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prescription details and the degree of adherence to 
insulin prescribing guidance (online supplementary 
table S3). Degree of adherence to prescription aspects of 
the guidance was scored for each area and the result was 
inputted into a run chart to detect any common cause 
variation.
Two of the 10 discharged patients examined at base-
line were prescribed two insulin products on discharge, 
making the total number of insulin prescriptions 
measured at baseline equal to 12. None of the discharge 
prescriptions complied fully with the guidance measures. 
One patient’s insulin (two products) was completely 
omitted from the discharge prescription (thereby 
achieving 0% compliance). There were four prescriptions 
for ‘when required’ correctional insulin, two of which 
were judged to be unnecessary at the point of discharge 
(ie, ‘when required’ insulin had not been prescribed on 
admission nor for at least 7 days preceding discharge) 
and the other two did not contain clear instructions 
for use. Only three discharge prescriptions mentioned 
arrangements for insulin administration at home. Seventy 
per cent of prescribed insulin contained sufficient infor-
mation about the product, dose, frequency, device and 
time and 44% explicitly described the changes made to 
insulin since admission. Results from baseline data collec-
tion therefore confirmed that insulin prescribing quality 
at discharge required improvement.
Although the use of the overall scoring system used to 
measure improvement involved making quality judge-
ments and did not focus on adherence to one partic-
ular measure of improvement, it did allow for a more 
general assessment of the quality of insulin prescriptions 
on discharge. As such, the team decided to use the same 
proforma to collect data chronologically throughout the 
project, which ran over the following 3 weeks.
Throughout the project, data were retrospectively 
collected using the hospital’s EPMA system by the same 
individual at the end of the week to ensure reliable and 
complete collection that did not impede on workflow 
in real time. In order to increase rigour and limit bias, 
a second pharmacist independently reviewed the data 
collection tool and the quality judgements made using 
the scoring system. No identifiable patient details were 
recorded on the proforma. All data were anonymised and 
kept confidentially on a secure personal drive only avail-
able via a hospital-networked computer.
design
The baseline data relating to insulin discharge prescrip-
tions were discussed within the multidisciplinary project 
team, and it was agreed that an intervention to improve 
the quality of discharges was needed. The team communi-
cated frequently via email and members of the team met 
in person at various intervals (eg, some members met 
weekly, others monthly) to discuss the project progress. 
The members of the team were key stakeholders in the 
insulin safety and diabetes care agenda and were there-
fore ideally placed to help the sustainability of the project.
Insulin discharge guidelines were developed by project 
team consensus and posters were designed to display 
the guidance on the selected ward areas (figure 1). All 
members of the project team worked with staff on the 
ward to inform the design of interventions, as well as facil-
itatetheir implementation and development throughout 
the project.
The posters were developed through several iterations 
by the project team leader, informed by feedback from all 
members of the project team, over a 2-week period before 
being introduced on the ward. Posters were displayed, 
with consent from ward staff, around workstations where 
electronic prescribing occurred. In order to increase the 
impact of the poster on improving patient safety, it was 
felt that the poster should include guidance on all rele-
vant and problematic areas of the discharge process. The 
poster would therefore be a more useful reference for 
staff undertaking patient discharges, despite the measure-
ment of adherence to only specific elements of guidance.
Posters were designed to be engaging, readable, rele-
vant and understandable, with clear navigation planes and 
drawing on the principals of the national ‘Think Glucose’ 
campaign.27 28 Feedback on the posters and guidance was 
obtained via informal qualitative interviews and helped to 
inform future iterations of the project.
An integrated approach to introducing the guidelines 
was taken in order to help engage the intended audience 
and improve knowledge transfer as well as a change in 
attitudes and behaviour.29 This involved early reciprocal 
dialogue with healthcare professionals on the ward, as 
well as engagement of senior staff. The early involve-
ment of the trust-wide diabetes team, as well as dedicated 
educational sessions, inclusion in the hospital’s diabetes 
educational packages and integration into the EPMA 
system helped to enable scale and sustainability of the 
intervention.
sTraTegy
Our aim was to improve the quality of insulin discharge 
prescriptions on one diabetes ward so that all prescrip-
tions complied with the new insulin prescribing guid-
ance within 3 weeks. Our main outcome measure was the 
quality of insulin discharge prescriptions being issued 
from the diabetes ward, which was assessed by a combina-
tion of quality judgements and measures, resulting in an 
overall percentage score for each prescription. The data 
were measured continuously and remotely over a total 
period of 4 weeks, with all discharges involving insulin 
from the ward (Monday–Friday) being included. We 
undertook three ‘plan-do-study-act’ (PDSA) test cycles 
over the 3-week intervention period.
Pdsa cycle 1
Our initial intervention was to introduce the posters on 
the ward areas and explain the project to the nursing, 
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Figure 1 Insulin safety poster: ‘improving insulin safety 
on discharge’ (A) and project rationale poster, ‘safer insulin 
prescribing’ (B) introduced to the ward in plan-do-study-act 
(PDSA) cycle 1. EPMA, electronic prescribing and medicines 
administration.
medical and pharmacy staff on the ward over the course 
of one afternoon. Ward staff were positive about the need 
for the guidance and the look of the posters, and agreed 
where the posters should be displayed on ward areas so 
that they could be referred to when discharging patients. 
This resulted in an increase of adherence to guidance by 
an average of 22%. Feedback received indicated that the 
posters were a helpful prompt for all ward staff involved 
in discharging patients using insulin.
Pdsa cycle 2
The particular lack of documentation regarding insulin 
administration arrangements on discharge was evident 
during continuous data collection. On further investiga-
tion, it was found that, although the diabetes management 
and monitoring chart has a designated section on insulin 
self-administration status, this was very rarely completed. 
As a result, insulin administration information was not 
easily accessible on the EPMA system. The team decided 
if self-administration status was included as a ‘free-text’ 
prescription item as part of the medicines reconciliation 
process on admission, staff would be clearly informed 
from the point of admission. As others have shown, this 
should prompt consideration of self-management during 
admission and promoting insulin safety,30 and allow early 
referral to the diabetes specialist nurse if district nurse 
input was required for insulin administration at home. 
As a result of this small adjustment to the medicines 
reconciliation process on admission, compliance with the 
overall guidance increased by a further 20%.
Pdsa cycle 3
After discussion with the ward team, who felt clearer, 
tailored instruction was needed for particular profes-
sional groups (eg, nurses, pharmacists, doctors), a check-
list was created for nurses to actively use when discharging 
patients with insulin (figure 2). Checklists have been 
shown to be useful for improving patient safety in various 
clinical settings by strengthening compliance with guide-
lines, improving human factors and reducing the inci-
dence of adverse events.31 An iterative process of check-
list design was employed with consultation with the team, 
and interestingly, highlighted slight variations in practice 
that could be addressed to provide a more consistent 
approach to patient safety. Checklists were designed to 
be clear, simple and further prompt a systematic process 
to ensuring good practice when discharging patients with 
insulin. Although ‘checklist compliance’ was not meas-
ured due to its poor reflection of task execution,32 after 
their introduction, there was an additional 7% improve-
ment in overall guideline compliance.
resulTs
One-week baseline measurement of 10 patients (12 
insulin prescriptions) showed normal variation, and after 
each intervention, a general upward trend was observed. 
After three consecutive PDSA cycles involving a further 
16 patients (20 insulin prescriptions) over the following 
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Figure 2 Insulin discharge checklist for nursing staff on 
the ward, implemented in plan-do-study-act (PDSA) cycle 3. 
PRN, when required; DSN, Diabetes Specialist Nurse; TTO, 
discharge prescription; BG, blood glucose; NB, nota bene 
(note well); RH2, Robert Hadfield 2 ward.
Figure 3 Run chart of insulin discharge prescription guideline compliance throughout the project. PDSA, plan-do-study-act.
3 weeks, the average compliance with the guidelines 
increased from 50% to 99%, and was consistently above 
90% during the final week of data collection (figure 3).
Improvements were seen in all aspects of quality 
measures listed in online supplementary table S2, 
resulting in clearer and more descriptive discharge 
prescriptions for insulin. Feedback from ward staff was 
that the interventions resulted in improved interface 
communication and safer insulin prescribing for patients 
being discharged from hospital.
An unintended but predictable consequence of the 
intervention was a slightly increased time taken for phar-
macy to undertake medicines reconciliation on admission 
and clinically verify insulin discharge prescriptions. This 
was not unacceptable to pharmacy staff, however, due to 
the perceived positive impact on patient safety:
I think it will have a positive impact on patient safety, 
so I think every minute spent on the documentation 
is worth it!
Pharmacy staff on the ward described a heightened vigi-
lance as a result of the poster, particularly with respect to 
the inappropriate prescribing of ‘when required’ insulin 
on discharge, which they described making interventions 
in for three patients during the project. This highlighted 
a further ongoing need to engage with prescribers with 
respect to this particular quality measure. Medical and 
nursing staff commented that the posters were attractive 
and informative, and were positive about their potential 
impact on patient safety.
lessons and limiTaTions
The project aim was to improve the quality of insulin 
discharge prescriptions in a way that would be sustainable 
and transferable to different ward environments. As such, 
although interventions were implemented and developed 
on a single ward, they targeted the problems identified 
at a trust-wide level. The need for change was described 
pictorially with the use of objective data, which helped to 
highlight the need for change in a way that did not target 
or criticise particular staff members, professional groups 
or ward teams.33
A key lesson learnt during the process was the impor-
tance of the early and continuous involvement of the 
multidisciplinary team (both at ward and directorate 
levels) in designing and modifying interventions. As the 
changes designed were acceptable to the variety of profes-
sionals involved in the discharge process, this helped to 
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validate the intervention and encourage its viability. The 
continuous measurement of data and discussion with ward 
staff to optimise iterative interventions before scaling was 
key.34 As scaling the intervention on a trust-wide level will 
involve discussion at governance committee level, efforts 
to engage wider senior staff early on in the intervention 
design process may be made to increase efficiency in 
future projects.
Data were collected on discharge prescriptions that had 
been completed and verified, thereby reflecting the final 
document received by general practitioners. Any undoc-
umented pharmacist or nursing interventions were there-
fore not reflected in the quantitative data. Anecdotal 
qualitative evidence was collected as recommended by 
Pope et al,35 despite its limitations and potential biases, 
to help contextualise and compensate for the limitations 
in the type of measures being monitored. Balancing 
measures were also considered, such as the time taken 
to undertake medicines reconciliation on admission and 
pharmacist clinical verification.
Future efforts to measure adherence to other areas 
of the guidance (eg, concerning patient communi-
cation and checks made around insulin equipment 
provision) may be considered to allow a more holistic 
assessment of discharge quality and success of the inter-
vention. Remote data collection may have minimised 
bias and observer (Hawthorne) effect, but all ward staff 
were aware that the success of the intervention would 
be measured. Future projects may benefit from more 
rigorous study design, for example, involving a ‘control’ 
ward and validation of measurement tools, as described 
by Portela et al.36
Ward staff demonstrated positive engagement with 
the project. This could be due to a combination of 
factors, including their interest in diabetes care, the high 
frequency of patients being discharged with insulin from 
the ward, and the appreciation that discharges from the 
ward have been problematic in the recent past. Non-dia-
betes wards that do not discharge many patients on insulin 
may not be as motivated to engage with QI measures in 
this area, and the same intervention(s) may not result in 
the improvements seen in this short project. The presence 
of diabetes link nurses and diabetes outreach services 
may, however, offer a potential solution to this. Also, not 
all discharge prescriptions from the diabetes ward are 
checked by diabetes pharmacists, particularly if patients 
are being discharged out of hours. The engagement of 
the wider pharmacy team will therefore be required for 
improvements to be consistent.
After further roll-out of the intervention, the re-audit 
of insulin discharge quality will be required to demon-
strate the sustainability of change, and would need to 
take into account potential positive confounding bias and 
natural process variation that may affect the results (eg, 
the change of rotational junior doctor and pharmacy staff 
on the ward, as well as local ward processes may affect 
the results independently of the intervention). Statistical 
analysis would need to be performed on a larger data set 
obtained over a longer period of time in order to increase 
the reliability of the results.
conclusion
It is widely known that insulin is a high-risk drug that is 
frequently implicated in medication errors in hospital, 
particularly at the point-of-care transfer. Our aim was to 
achieve compliance with new consensus-derived, local 
insulin discharge guidance after the series of inter-
ventions, which we achieved in over 90% by the end of 
the project. This resulted in clearer communication of 
insulin information across the interface on discharge 
prescriptions as well as a reduction in insulin prescribing 
errors. With appropriate resources, the extra time taken 
to undertake comprehensive medicines reconciliation on 
transfer of care would be beneficial in helping to improve 
the safe use of insulin for patients. Continued measure-
ment of medication safety incidents and errors would 
be required in order to demonstrate sustainability and 
success of the intervention.
The focus of the project was adjusted slightly in light 
of what aspects of discharge quality could be realisti-
cally and reliably measured. This included optimising 
the process of medicines reconciliation using the elec-
tronic prescribing system in order to clearly communi-
cate important information regarding insulin therapy. 
In this sense, the project was useful in identifying what 
specific aspects of discharge prescriptions could easily be 
improved, and how EPMA could be better used to opti-
mise communication in order to increase patient safety.
Due to the considerable improvement seen by the inter-
ventions in this project, Trust-wide scale up is currently 
underway. Diabetes link nurses have been informed and 
engaged in the project and measures have been taken to 
integrate the interventions into the existing EPMA system 
and nursing discharge planning processes. Further work 
is being considered to develop further educational mate-
rials for staff that can be integrated into existing systems 
to promote the safe use of insulin in hospital.
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